Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sedative effect of cyclopofol vs propofol with sufentanil in painless gastroscopy for obese patients
ChiCTR2300074217Phase 4Not yet recruiting
- Sponsor
- Hangzhou Red Cross Hospital
- Start
- Aug 2023
- Modality
- Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of ciprofol and propofol in obesity (2 arms), sponsored by Hangzhou Red Cross Hospital. Primary endpoint: Incidence of intraoperative hypoxia. Planned start Aug 2023; status: not yet recruiting.
02
Drugs
ciprofolpropofol
03
Conditions
obesity
Beyond the preview
Go deeper on ChiCTR2300074217.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300074217.